Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC decreased its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 3.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 58,619 shares of the company’s stock after selling 2,214 shares during the quarter. Mutual of America Capital Management LLC owned about 0.32% of Addus HomeCare worth $6,806,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ADUS. Principal Securities Inc. purchased a new position in shares of Addus HomeCare during the 4th quarter worth $26,000. UMB Bank n.a. boosted its stake in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after buying an additional 88 shares during the period. Quest Partners LLC acquired a new stake in shares of Addus HomeCare during the second quarter valued at about $31,000. EntryPoint Capital LLC purchased a new stake in shares of Addus HomeCare in the 1st quarter valued at approximately $44,000. Finally, Innealta Capital LLC acquired a new position in shares of Addus HomeCare in the 2nd quarter worth approximately $44,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on ADUS. TD Cowen lifted their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. StockNews.com downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 7th. Royal Bank of Canada reissued an “outperform” rating and set a $141.00 target price on shares of Addus HomeCare in a research note on Tuesday, September 3rd. Oppenheimer increased their price target on shares of Addus HomeCare from $130.00 to $140.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 7th. Finally, Macquarie assumed coverage on shares of Addus HomeCare in a research report on Friday, June 28th. They set an “outperform” rating and a $136.00 price target on the stock. One analyst has rated the stock with a sell rating and eight have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $127.57.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at $429,165. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. The disclosure for this sale can be found here. Insiders have sold 22,917 shares of company stock valued at $3,050,082 over the last quarter. 4.60% of the stock is owned by insiders.

Addus HomeCare Price Performance

ADUS stock opened at $133.05 on Friday. Addus HomeCare Co. has a 1 year low of $78.35 and a 1 year high of $136.12. The firm has a market capitalization of $2.41 billion, a P/E ratio of 33.01, a P/E/G ratio of 2.33 and a beta of 1.04. The business’s 50-day moving average is $126.62 and its two-hundred day moving average is $113.68.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The company had revenue of $286.90 million during the quarter, compared to the consensus estimate of $284.90 million. During the same quarter in the previous year, the firm earned $0.94 earnings per share. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. On average, analysts expect that Addus HomeCare Co. will post 4.58 EPS for the current year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.